Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
305 studies found for:    Thrombocytopenia: Clinical Trials
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Probiotic Agent;   Drug: Dexamethasone
2 Not yet recruiting A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Bortezomib
3 Terminated Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: recombinant human thrombopoietin
4 Recruiting TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
Conditions: Hematologic Neoplasms;   Hemorrhage;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: Tranexamic acid (TXA).;   Drug: Placebo
5 Recruiting Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Warfarin, NOAC
6 Unknown  The HIT-TRAP Trial
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: Standard heparin (UFH) versus certoparin (LMWH)
7 Recruiting A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Conditions: Alloimmune Thrombocytopenia;   Fetal Alloimmune Thrombocytopenia
Intervention: Drug: IVIG (Intravenous Immunoglobulin)
8 Recruiting American Trial Using Tranexamic Acid in Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
9 Completed WEUSKOP5410: Observational Study in ENABLE Clinical Trials
Condition: Hepatitis C
Intervention: Drug: eltrombopag
10 Completed
Has Results
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
Conditions: Chemotherapy-Induced Thrombocytopenia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Cancer;   Oncology;   Thrombocytopenia
Intervention: Biological: AMG 531
11 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Conditions: Antineoplastic Adverse Reaction;   Thrombocytopenia;   Acute Myelocytic Leukemia
Intervention: Drug: rhTPO
12 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Drug: rhTPO
13 Completed
Has Results
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Chemotherapy-Induced Thrombocytopenia;   Non-Small Cell Lung Cancer;   Cancer;   Lung Neoplasms;   Oncology;   Solid Tumors;   Thrombocytopenia
Interventions: Biological: Romiplostim;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin
14 Recruiting Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
Condition: Thrombocytopenia
Intervention: Drug: recombinant human thrombopoietin
15 Terminated A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Eltrombopag;   Drug: Avatrombopag
16 Recruiting The PROLONG Trial - Rituximab Maintenance Therapy in ITP
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Dexamethasone;   Drug: Rituximab
17 Completed Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: argatroban
18 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
19 Unknown  Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia
Condition: Non-Hodgkin Lymphoma
Intervention: Drug: Romiplostim
20 Completed An Open-label Safety Study of S-888711
Condition: Immune Thrombocytopenia
Intervention: Drug: 0.5 mg of S-888711

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.